|   
							Manual COVID-19 para el neurólogo general 
							  
							
							SNE. 2020. Manual COVID-19 para el neurólogo general.
							Ediciones SEN. San Sebastian de los Reyes, Madrid. España
 
 Ver documento » 
 |  
 
							COVID-19 in Children: Initial Characterization of the Pediatric Disease
 
							Cruz A, Zeichner S. COVID-19 in children: initial characterization of the pediatric disease.Pediatrics. 2020; doi: 10.1542/peds.2020-0834
 
 Ver documento » 
 |  
 
							Neurological Manifestations of Hospitalized Patients with COVID-19
							in Wuhan, China: a retrospective case series study 
							Ling Mao, Mengdie Wang,
							et al. Neurological Manifestations of Hospitalized Patients with COVID-19
							in Wuhan, China: a retrospective case series study.
 Ver documento » 
 | 
		
			|  
 
							Anosmia and ageusia: common findings in COVID-19 patients.Otolaryngological manifestations in COVID-19
 
							  
							Luigi Angelo Vaira,MD; Giovanni Salzano MD; Giovanna Deiana MD; Giacomo De Riu MD, FEBOMFS.,doi: 10.1002/lary.28692.,
 
 Ver documento » 
 |  
 
									COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Capturesthe Porphyrin to Inhibit Human Heme Metabolism
 
									 Wenzhong Liu, Hualan Li
									 
									  Ver documento »
 |  
 
							Neurological Complications of CoronavirusDisease (COVID-19): Encephalopathy
 
 
							Filatov A, Sharma P, Hindi F, et al. (March 21, 2020) Neurological Complications of Coronavirus Disease
                            (COVID-19): Encephalopathy. Cureus 12(3): e7352. DOI 10.7759/cureus.7352 Ver documento » 
 | 
		
			|   
							Clinically relevant Drug-Drug interaction between AEDs and 
							medications used in the treatment of COVID-19
							  
							E. Russo and L. Iannone (University of Catanzaro, Italy) on behalf of LICE
							Lega Italiana Contro l’Epilessia (LICE) – Italian League Against Epilepsy
							 
 
 Ver documento »
 |  
 
									Decálogo de recomendaciones para profesionales
									del ámbito sanitario para un afrontamiento
									psicológico eficaz ante el malestar generado
									por el brote de Coronavirus-Covid 19  
									 Colegio Oficial de la Psicología de Madrid
									 Ver documento »
 |  
 
							COVID-19: Neurologists in Italy to Colleagues in US: Lookfor Poorly-Defined Neurologic Conditions in Patients with
 the Coronavirus
 
							Jaime Talan. 2020. COVID-19: Neurologists in Italy to Colleagues in US: Look
							for Poorly-Defined Neurologic Conditions in Patients withthe Coronavirus. Neurology Today.
 Ver documento » 
 | 
		
			|  
 
									Brain Awareness Week, CoVID-19 infection and Neurological Sciences  
									  
									Antonio Federico.2020.Brain Awareness Week, CoVID-19 infection and Neurological Sciences
									Neurological Sciences. https://doi.org/10.1007/s10072-020-04338-0 
									 Ver documento » 
 |  
 
									Evidence of the COVID-19 Virus Targeting the CNS: Tissue
									Distribution, Host−Virus Interaction, and Proposed Neurotropic
									Mechanisms  
									Abdul Mannan Baig,Areeba Khaleeq, Usman Ali, and Hira Syeda.https://dx.doi.org/10.1021/acschemneuro.0c00122
 Ver documento » 
 |  
 
							The neuroinvasive potential of SARS−CoV2 may play a role
							in the respiratory failure of COVID−19 patients 
							Li Y−C, Bai W−Z, Hashikawa T. The neuroinvasive potential of SARS−CoV2 may play a role in the
							respiratory failure of COVID−19 patients. J Med Virol.
 2020;1−4. https://doi.org/10.1002/jmv.25728
 Ver documento » 
 | 
		
			|  
  
							Consensus for prevention andmanagement of coronavirus disease 2019
 (COVID-19) for neurologists
 Jin H, Hong C, Chen S,
							et al. Consensus for preventionand management of coronavirus
							disease 2019 (COVID-19) for
 neurologists. Stroke & Vascular
							Neurology 2020;0. doi:10.1136/
							svn-2020-000382
 Ver documento »
 |   
									Evidence summary for natural history of COVID-19 in children  
									Health Information and Quality Authority
 
 
 Ver documento » 
 |  
 
							Renin–Angiotensin–Aldosterone SystemInhibitors in Patients with Covid-19
 
							Muthiah Vaduganathan, M.D., et. al,
							Renin–Angiotensin–Aldosterone System
							Inhibitors in Patients with Covid-19
							The New England Journal of Medicine 
							DOI: 10.1056/NEJMsr2005760 Ver documento » 
 | 
		  
		|  
 
							COVID-19 infection in children 
							https://doi.org/10.1016/S2213-2600(20)30152-1  
 Ver documento »
 |  
 
									Characteristics of and Important Lessons Fromthe Coronavirus Disease 2019 (COVID-19) Outbreak in China
 Summary of a Report of 72 314 Cases From
 the Chinese Center for Disease Control and Prevention
 
									ZunyouWu,MD, PhD; Jennifer M.McGoogan, PhDJAMA. 2020
 Ver documento » 
 |  
 
							Nervous system involvement after infection withCOVID-19 and other coronaviruses
 
 
							Yeshun Wu, et al., Brain, Behavior, and Immunity,https://doi.org/10.1016/j.bbi.2020.03.031
 Ver documento » 
 | 
		
		  
		|  
 
							COVID-19 and Diabetes: Knowledge in Progress 
							A. Hussain, B. Bhowmik, N. Cristina do Vale Moreira, COVID-19 and Diabetes:Knowledge in Progress, Diabetes Research and Clinical Practice (2020),
 doi: https://doi.org/10.1016/j.diabres.2020.108142
 Ver documento »
 |  
 
									COVID-19 por especialidades y temas  
									Bibliotecas de Ciencias de la Salud
 Ver enlace» 
 |  
 
							Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy 
							Luca Carsana, MD1
							Aurelio Sonzogni, MD2
							Ahmed Nasr, MD2
							Roberta Simona Rossi, MD1
							Alessandro Pellegrinelli, MD1 Ver documento »
 | 
		
		  
		| 
  
 
							Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
							 
							Dimitrios Giannis, Ioannis A. Ziogas, Panagiota Gianni
 Ver documento »
 |  |  |